Department of Neurosurgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 300 Community Dr Manhasset, Hempstead, NY, 11030, USA.
Community Neurosciences Institute, Community Health Partners, Fresno, CA, USA.
Neurosurg Rev. 2023 Oct 16;46(1):271. doi: 10.1007/s10143-023-02167-1.
Despite advances in endovascular treatment, microsurgical clipping of middle cerebral artery (MCA) aneurysms remains appropriate. We review the high occlusion rate and treatment durability seen with surgical clipping of MCA aneurysms. We retrospectively reviewed patients who underwent microsurgical clipping of saccular MCA aneurysms by a single surgeon. Outcomes included aneurysm occlusion rate and durability, modified Rankin scale (mRS), and postoperative neurological morbidities. Ninety-two patients with 92 saccular MCA aneurysms were included, 50% of which were ruptured aneurysms. The mean follow-up period was 59 months. Complete aneurysm occlusion was achieved in all except one patient (99%) with near-complete occlusion. MCA aneurysm clipping was durable, with only one patient (1%) requiring retreatment after 4 years due to regrowth. Of the cohort, 79.3% achieved mRS 0-2 at last follow-up, including all with unruptured aneurysms. Poor outcome at discharge was associated with age > 65 (p = .03), postoperative neurological morbidities (p = .006), and aneurysm rupture (p < .001). Older age remained the single correlate for poor long-term outcome (p = .04). For ruptured aneurysms, predictors of poor long-term outcome included hemiparesis on presentation (p = .017), clinical vasospasm requiring treatment (p = .026), and infarction related to vasospasm (p = .041). Older age (p = .046) and complex anatomy (p = .036) were predictors of new postoperative neurological morbidities in the unruptured group. MCA aneurysm clipping is safe, durable, and should be considered first-line treatment for patients with saccular MCA aneurysms, especially in centers with abundant surgical experience.
尽管血管内治疗取得了进展,但对大脑中动脉(MCA)动脉瘤的显微手术夹闭仍然是合适的。我们回顾了手术夹闭 MCA 动脉瘤的高闭塞率和治疗持久性。我们回顾性分析了一位外科医生对囊状 MCA 动脉瘤进行显微手术夹闭的患者。结果包括动脉瘤闭塞率和持久性、改良 Rankin 量表(mRS)和术后神经并发症。92 例囊状 MCA 动脉瘤患者纳入研究,其中 50%为破裂动脉瘤。平均随访时间为 59 个月。除 1 例(99%)患者因接近完全闭塞外,所有患者均实现完全动脉瘤闭塞。MCA 动脉瘤夹闭是持久的,只有 1 例(1%)患者在 4 年后因复发需要再次治疗。在该队列中,79.3%的患者在最后一次随访时达到 mRS 0-2,包括所有未破裂动脉瘤患者。出院时预后不良与年龄>65 岁(p=0.03)、术后神经并发症(p=0.006)和动脉瘤破裂(p<0.001)相关。老年是长期预后不良的唯一相关因素(p=0.04)。对于破裂动脉瘤,不良长期预后的预测因素包括发病时偏瘫(p=0.017)、需要治疗的临床血管痉挛(p=0.026)和与血管痉挛相关的梗死(p=0.041)。年龄较大(p=0.046)和复杂解剖结构(p=0.036)是未破裂组术后新发神经并发症的预测因素。MCA 动脉瘤夹闭是安全的,持久的,应被视为囊状 MCA 动脉瘤患者的一线治疗方法,特别是在具有丰富手术经验的中心。